↑ 疾患リストへ ← 戻る

 263. 脳腱黄色腫症 [臨床試験数:3,薬物数:3(DrugBank:2),標的遺伝子数:2,標的パスウェイ数:4] 

Searched query = "Cerebrotendinous xanthomatosis", "27-hydroxylase deficiency", "CYP27 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"    Synonyms (DrugBank) were also searched for.
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01613898August 201019 February 2015Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous XanthomatosisEvaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous XanthomatosisCerebrotendinous Xanthomatosis (CTX)Biological: Blood testsSheba Medical CenterRecruiting10 YearsN/ABoth17N/AIsrael
2NCT00018694October 199919 February 2015Cholestanol in HumansBiologic Significance of Cholestanol in ManCerebrotendinous XanthomatosisDrug: Chenodeoxycholic AcidDepartment of Veterans AffairsNot recruiting5 Years80 YearsBoth0N/AUnited States
3NCT00004346January 199619 February 2015Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous XanthomatosisEffects of Diet and Medication in Patients With Cerebrotendinous Xanthomatosis (CTX)Cerebrotendinous XanthomatosisDrug: chenodeoxycholic acid;Drug: lovastatinNational Center for Research Resources (NCRR)Oregon Health and Science UniversityRecruitingN/AN/ABoth5Phase 2United States